PURPOSE: Solid Lipid Nanoparticles (SLN) are an alternative carrier system for the controlled delivery of drugs. In most cases prednisolone loaded SLN show a biphasic release behaviour. The initial phase is characterised by a fast drug release, which is followed by a sustained drug release over several weeks. METHODS: The particles are produced by high pressure homogenisation of a lipid (e.g. compritol, cholesterol) dispersed in an aqueous surfactant solution. In this study atomic force microscopy was used to image the original unaltered shape and surface properties of the particles. The crystallinity of the nanoparticles was investigated by differential scanning calorimetry. RESULTS: The AFM investigations revealed the disc like shape of the particles. From differential scanning calorimetry data it can be concluded that the particle core is in the crystalline state. Additionally it was proven that the particles are surrounded by a soft layer. CONCLUSIONS: Thus it is conceivable that the fast initial drug release during in vitro dissolution tests takes place by drug release of the outer noncrystalline layers of the particles. The following sustained drug release can be assigned to the predisolone release of the inner crystalline particle layers.
PURPOSE: Solid Lipid Nanoparticles (SLN) are an alternative carrier system for the controlled delivery of drugs. In most cases prednisolone loaded SLN show a biphasic release behaviour. The initial phase is characterised by a fast drug release, which is followed by a sustained drug release over several weeks. METHODS: The particles are produced by high pressure homogenisation of a lipid (e.g. compritol, cholesterol) dispersed in an aqueous surfactant solution. In this study atomic force microscopy was used to image the original unaltered shape and surface properties of the particles. The crystallinity of the nanoparticles was investigated by differential scanning calorimetry. RESULTS: The AFM investigations revealed the disc like shape of the particles. From differential scanning calorimetry data it can be concluded that the particle core is in the crystalline state. Additionally it was proven that the particles are surrounded by a soft layer. CONCLUSIONS: Thus it is conceivable that the fast initial drug release during in vitro dissolution tests takes place by drug release of the outer noncrystalline layers of the particles. The following sustained drug release can be assigned to the predisolone release of the inner crystalline particle layers.
Authors: B Drake; C B Prater; A L Weisenhorn; S A Gould; T R Albrecht; C F Quate; D S Cannell; H G Hansma; P K Hansma Journal: Science Date: 1989-03-24 Impact factor: 47.728
Authors: Huaiqiu Galen Shi; Leon Farber; James N Michaels; Allison Dickey; Karen C Thompson; Suhas D Shelukar; Patricia N Hurter; Scott D Reynolds; Michael J Kaufman Journal: Pharm Res Date: 2003-03 Impact factor: 4.200
Authors: Rúbia Casagrande; Sandra R Georgetti; Waldiceu A Verri; José R Jabor; Antonio C Santos; Maria J V Fonseca Journal: AAPS PharmSciTech Date: 2006-02-03 Impact factor: 3.246
Authors: Shady M Abd El-Halim; Ghada A Abdelbary; Maha M Amin; Mohamed Y Zakaria; Hesham A Shamsel-Din; Ahmed B Ibrahim Journal: Daru Date: 2020-06-20 Impact factor: 3.117
Authors: Nirmal V Shah; Avinash K Seth; R Balaraman; Chintan J Aundhia; Rajesh A Maheshwari; Ghanshyam R Parmar Journal: J Adv Res Date: 2016-03-05 Impact factor: 10.479
Authors: Alaa Eldeen B Yassin; Md Khalid Anwer; Hammam A Mowafy; Ibrahim M El-Bagory; Mohsen A Bayomi; Ibrahim A Alsarra Journal: Int J Med Sci Date: 2010-11-22 Impact factor: 3.738